对比增强CT与增强MRI联合MRCP评估肝外胆管癌可切除性的比较
该回顾性研究纳入214例病理确诊的初治肝外胆管癌患者,比较CECT与CE-MRI联合MRCP评估可切除性的诊断性能。两种方法在AUC、敏感度和特异度上无显著差异,观察者间一致性均为fair。当两种方法结果不一致或不确定时,联合审阅可提高AUC。
要点
- CECT与CE-MRI联合MRCP评估肝外胆管癌可切除性的诊断性能无显著差异。
- 两种方法的观察者间一致性均为fair(κ约0.32),无显著差异。
- 当两种方法结果不一致或不确定时,联合审阅可提高可切除性评估的AUC。
核心结论
- CECT与CE-MRI联合MRCP在评估肝外胆管癌可切除性方面诊断性能和观察者间一致性无显著差异。
- 在两种方法结果不一致或可切除性不确定时,联合审阅可提高AUC。
研究设计与样本
- 回顾性研究纳入214例病理确诊的初治肝外胆管癌患者,其中146例男性,平均年龄68±9岁,121例(56.5%)为肝门部胆管癌。
- 患者均接受CECT和CE-MRI联合MRCP(使用细胞外对比剂)检查,检查时间范围为2015年1月至2020年12月。
- 四位经过专科培训的放射科医生独立审阅CECT和CE-MRI联合MRCP图像,评估局部肿瘤范围和远处转移以确定可切除性。
- 以临床、手术和病理结果为参考标准,比较两种方法的汇总AUC、敏感度和特异度,并使用Fleiss kappa评估观察者间一致性。
诊断标准与关键数值
- CECT与CE-MRI联合MRCP的汇总AUC分别为0.753和0.767,无显著差异。
- CECT的敏感度为84.7%(366/432),CE-MRI联合MRCP为90.3%(390/432),无显著差异。
- CECT的特异度为52.6%(223/424),CE-MRI联合MRCP为51.4%(218/424),无显著差异。
- 观察者间一致性:CECT的κ=0.323,CE-MRI联合MRCP的κ=0.320,两者无显著差异(P=0.884)。
临床应用与阅片要点
- 对于肝外胆管癌可切除性评估,CECT和CE-MRI联合MRCP均可作为可选方法,诊断性能相当。
- 当两种方法结果不一致或可切除性不确定时,建议联合审阅CECT和CE-MRI联合MRCP以提高评估准确性。
- 由于观察者间一致性仅为fair,报告可切除性时需注意一致性限制,必要时多学科讨论。
局限性
- 本研究为回顾性研究,可能存在选择偏倚。
- 观察者间一致性仅为fair,可能影响可切除性评估的可靠性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare the diagnostic performance and interobserver agreement between contrast-enhanced computed tomography (CECT) and contrast-enhanced magnetic resonance imaging (CE-MRI) with magnetic resonance cholangiopancreatography (MRCP) for evaluating the resectability in patients with extrahepatic cholangiocarcinoma (eCCA).
MATERIALS AND METHODS: This retrospective study included treatment-naïve patients with pathologically confirmed eCCA, who underwent both CECT and CE-MRI with MRCP using extracellular contrast media between January 2015 and December 2020. Among the 214 patients (146 males; mean age ± standard deviation, 68 ± 9 years) included, 121 (56.5%) had perihilar cholangiocarcinoma. R0 resection was achieved in 108 of the 153 (70.6%) patients who underwent curative-intent surgery. Four fellowship-trained radiologists independently reviewed the findings of both CECT and CE-MRI with MRCP to assess the local tumor extent and distant metastasis for determining resectability. The pooled area under the receiver operating characteristic curve (AUC), sensitivity, and specificity of CECT and CE-MRI with MRCP were compared using clinical, surgical, and pathological findings as reference standards. The interobserver agreement of resectability was evaluated using Fleiss kappa (κ).
RESULTS: No significant differences were observed between CECT and CE-MRI with MRCP in the pooled AUC (0.753 vs. 0.767), sensitivity (84.7% [366/432] vs. 90.3% [390/432]), and specificity (52.6% [223/424] vs. 51.4% [218/424]) (P > 0.05 for all). The AUC for determining resectability was higher when CECT and CE-MRI with MRCP were reviewed together than when CECT was reviewed alone in patients with discrepancies between the imaging modalities or with indeterminate resectability (0.798 [0.754-0.841] vs. 0.753 [0.697-0.808], P = 0.014). The interobserver agreement for overall resectability was fair for both CECT (κ = 0.323) and CE-MRI with MRCP (κ = 0.320), without a significant difference (P = 0.884).
CONCLUSION: CECT and CE-MRI with MRCP showed no significant differences in the diagnostic performance and interobserver agreement in determining the resectability in patients with eCCA.
引用
- Yoo J, Lee JM, Kang HJ, et al. Comparison Between Contrast-Enhanced Computed Tomography and Contrast-Enhanced Magnetic Resonance Imaging With Magnetic Resonance Cholangiopancreatography for Resectability Assessment in Extrahepatic Cholangiocarcinoma. Korean J Radiol. 2023. PMID: 37793669. doi:10.3348/kjr.2023.0368
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。